Singh / Kumar / Chaturvedi / Khanna

Harnessing Nanozymes to Combat Antimicrobial Resistance

Springer

ISBN 978-3-032-16539-8

Standardpreis


213,99 €

Jetzt vorbestellen! Wir liefern bei Erscheinen (Erscheint vsl. März 2026)

Preisangaben inkl. MwSt. Abhängig von der Lieferadresse kann die MwSt. an der Kasse variieren. Weitere Informationen

Bibliografische Daten

Fachbuch

Buch. Hardcover

2026

Format (B x L): 15,5 x 23,5 cm

Verlag: Springer

ISBN: 978-3-032-16539-8

Produktbeschreibung

This book spotlights the potential of nanozymes in combating antimicrobial resistance (AMR), a growing global health crisis with high mortality and morbidity. Despite progress in understanding AMR, current therapies often fall short. Nanozymes, a novel class of enzyme-mimicking nanomaterials, offer diverse applications to address AMR and related infections. By enhancing targeted drug delivery, nanozyme-based treatments improve efficacy while reducing adverse effects, highlighting their potential to overcome the limitations of existing therapies.

AMR, driven by the overuse and misuse of antibiotics, is an escalating global challenge that results in resistant bacterial strains and significant health burdens. Current treatments lack optimal efficacy, emphasizing the need for innovative approaches. Nanozymes, with their enzyme-like catalytic activities at the nanoscale, present a promising solution to the complexities of AMR and associated infections.

Nanozymes offer a significant advantage in antimicrobial resistance (AMR) management by enhancing the efficacy of treatments. These formulations can navigate biological barriers with precision, improving drug bioavailability and minimizing off-target effects. Additionally, nanozymes facilitate early disease detection through advanced nano-imaging techniques, allowing the identification of infections and resistant bacteria at early stages-crucial for timely interventions. They can also carry anti-inflammatory agents, providing targeted relief and reducing systemic side effects.

In summary, nanozymes are a transformative tool in AMR management, addressing the limitations of current therapies. By improving drug delivery, enabling early detection, and offering precision therapeutics, nanozymes enhance treatment effectiveness while minimizing adverse effects. Their versatility opens avenues for personalized treatment regimens, paving the way for innovative, tailored healthcare solutions that can better meet the challenges of AMR, ultimately improving patient outcomes and public health.

This book targets scientists and researchers in AMR, drug delivery, and nanomaterials, covering AMR fundamentals to advanced nanozyme applications. It offers detailed, up-to-date insights, serving as a vital resource for students, clinicians, academics, and industry professionals across various scientific disciplines.

Autorinnen und Autoren

Produktsicherheit

Hersteller

Springer Nature Customer Service Center GmbH

Europaplatz 3
69115 Heidelberg, DE

ProductSafety@springernature.com

Topseller & Empfehlungen für Sie

Ihre zuletzt angesehenen Produkte

Rezensionen

Dieses Set enthält folgende Produkte:
    Auch in folgendem Set erhältlich:

    • Produktempfehlungen personalisieren

      Ihre Vorteile:

      • Empfehlungen basierend auf ihren Interessen
      • Zeitersparnis durch passende Vorschläge

      Mehr informationen zu , , und

      Die ersten personalisierten Empfehlungen erhalten Sie nach zwei bis drei Klicks.

      Sie können diese Zustimmung zu einem späteren Zeitpunkt unproblematisch über die Datenschutz-Einstellungen wieder zurückziehen.

      nach oben

      Ihre Daten werden geladen ...